BioCryst Pharmaceuticals Inc. BCRX
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
BioCryst Pharmaceuticals Inc. is a biotechnology company specializing in the research, development, and commercialization of novel small-molecule drugs that target key enzymes in infectious and inflammatory diseases. Leveraging expertise in biology, computer modeling, and medicinal chemistry, the company focuses on str…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees435
TickerBCRX
Statistics
Market Cap$2.25B
Revenue (TTM)$874.8M
Net Income$263.9M
Net Margin30.2%
EPS$1.21
P/E7.05
P/S2.44
P/B-3.72
EV/EBITDA8.28
ROE-221.4%
Dividend Yield—
Price$8.88
Data: Twelve Data · Revenue = mcap / P/S